- Ayataka Fujimoto, MD, PhDComprehensive Epilepsy Center, Seirei Hamamatsu General Hospital, JapanInterests: Epilepsy; Neurosurgery; Neurpsychology; Brain tumor; Pediatric neurology; Pediatric neurosurgery
Thanks to the latest anti-seizure medication (ASM), medication therapy can control epileptic seizures in many patients who have epilepsy, and it is said that about 70-80% of them can obtain freedom from seizures by ASMs. Comparing the old ASMs that include enzyme inducers, current ASMs have fewer side effects, and have good efficacy rates. However, even though ASMs contribute to the field of epilepsy, the rest of the patients with epilepsy cannot obtain freedom from seizures with ASMs alone, and need to choose other treatment options, such as epilepsy surgery, vagus nerve stimulation, ketogenic diet therapy, deep brain stimulation, responsive neurostimulation therapy, etc.
In terms of the non-medication treatment, seizure prediction might be one of the promising interventions. We already have seizure predicting canines. We may have devices to predict seizures in the near future.
The aim of this special issue is to focus on the non-medication treatment (prediction of seizures, epilepsy surgery, VNS, RNS, etc. in epilepsy treatment, basic research, medical engineering, etc.) for medically intractable epilepsy.
Dr. Ayataka Fujimoto and Dr. Tohru Okanishi
Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 2200 USD. Submitted manuscripts should be well formatted in good English.
- Outlines to Initiate Epilepsy Surgery in Low- and Middle-Income CountriesPeter Bäuerle, Ulf Schneider, Martin Holtkamp, Tengis Gloveli, Tamar DugladzeJ. Integr. Neurosci. 2022, 21(5), 134; https://doi.org/10.31083/j.jin2105134102Downloads1Citations296Views
- Effects of Stevia rebaudiana Bertoni extracts in the rat model of epilepsy induced by pentylenetetrazol: Sirt-1, at the crossroads between inflammation and apoptosisEman M. El Nashar, Walaa Obydah, Mansour A. Alghamdi, Somaya Saad, ... Abdelaziz M. HusseinJ. Integr. Neurosci. 2022, 21(1), 21; https://doi.org/10.31083/j.jin2101021170Downloads6Citations446Views
- Transcriptomic profile of epileptic children treated with ketogenic therapiesJana Ruiz-Herrero, Gloria Olaso-Gonzalez, Eva Serna, Elvira Cañedo-Villarroya, ... Jose VinaJ. Integr. Neurosci. 2022, 21(1), 31; https://doi.org/10.31083/j.jin2101031125Downloads1Citations410Views
- Neuropsychological performance after carotid endarterectomyLenka Krámská, Martin Kovář, Lucia Hrešková, Martin JerieJ. Integr. Neurosci. 2022, 21(1), 36; https://doi.org/10.31083/j.jin210103664Downloads1Citations275Views
- Surgical aspects using an exoscope for corpus callosotomy: initial experience for epilepsy surgeryKyoichi Tomoto, Toshiki Nozaki, Chikanori Inenaga, Ayataka FujimotoJ. Integr. Neurosci. 2022, 21(1), 39; https://doi.org/10.31083/j.jin210103985Downloads285Views